A detailed history of Gluskin Sheff & Assoc Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 18,556 shares of JNJ stock, worth $2.88 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
18,556
Previous 18,556 -0.0%
Holding current value
$2.88 Million
Previous $2.71 Million 10.88%
% of portfolio
0.37%
Previous 0.33%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $1,732 - $1,893
-12 Reduced 0.06%
18,556 $2.71 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $254,560 - $266,893
-1,640 Reduced 8.12%
18,568 $2.94 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $1.02 Million - $1.11 Million
-7,016 Reduced 25.77%
20,208 $3.17 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $564,749 - $632,664
-3,626 Reduced 11.75%
27,224 $4.24 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $768,971 - $827,560
-4,982 Reduced 13.9%
30,850 $5.11 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $283,218 - $337,987
-1,875 Reduced 4.97%
35,832 $5.55 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $25,632 - $28,766
-160 Reduced 0.42%
37,707 $6.66 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $645,642 - $718,439
4,002 Added 11.82%
37,867 $6.19 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $58,193 - $64,359
-346 Reduced 1.01%
33,865 $6.01 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $437,257 - $496,566
2,765 Added 8.79%
34,211 $6.06 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $729,440 - $809,340
4,678 Added 17.48%
31,446 $5.38 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $34,722 - $38,586
215 Added 0.81%
26,768 $4.32 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $62,356 - $66,888
391 Added 1.49%
26,553 $4.37 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $4 Million - $4.46 Million
26,162 New
26,162 $4.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.